van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, Bateman ED, Dheda K (2010). «Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD». Eur Respir J35 (1): 27-33. doi:10.1183/09031936.00072909. PMID20044459.
Gómez MI, Prince A (2007). «Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis». Curr Opin Pharmacol7 (3): 244-51. doi:10.1016/j.coph.2006.12.005. PMID17418640.
Klastersky J, Aoun M (2004). «Opportunistic infections in patients with cancer». Ann Oncol15 (suppl 4): 329-35. doi:10.1093/annonc/mdh947. PMID15477331.
d'Enfert C (2009). «Hidden killers: persistence of opportunistic fungal pathogens in the human host». Curr Opin Microbiol12 (4): 358-64. doi:10.1016/j.mib.2009.05.008. PMID19541532.
Reef SE, Mayer KH (1995). «Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities». Clin Infect Dis21 (Supplement 1): S99-S102. doi:10.1093/clinids/21.Supplement_1.S99. PMID8547520.
Castro KG (1995). «Tuberculosis as an opportunistic disease in persons infected with human immunodeficiency virus». Clin Infect Dis21 (Supplement 1): S66-S71. doi:10.1093/clinids/21.Supplement_1.S66. PMID8547515.
Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971 pmid = 4104715). «Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy». Lancet1 (7712): 1257–60. doi:10.1016/S0140-6736(71)91777-6.
Martínez E, García-Viejo MA, Marcos MA, et al. (2000). «Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy». AIDS14 (16): 2615–26. doi:10.1097/00002030-200011100-00029. PMID11101078.
Vibhagool A, Sungkanuparph S, Mootsikapun P, et al. (2003). «Discontinuation of secondary prophylaxis for Cryptococcal meningitis in Human Immunodeficiency Virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study». Clin Infect Dis36 (10): 1329–31. doi:10.1086/374849. PMID12746781.
Aliouat-Denis, C-M. et al. (2008). «Pneumocystis species, co-evolution and pathogenic power». Infection, Genetics & Evolution8 (5): 708–726. doi:10.1016/j.meegid.2008.05.001. PMID18565802.
Laveran CL (1982). «Classics in infectious diseases: A newly discovered parasite in the blood of patients suffering from malaria. Parasitic etiology of attacks of malaria: Charles Louis Alphonse Laveran (1845-1922)». Rev Infect Dis4 (4): 908-11. PMID6750753.
Sutherland CJ & Hallett R (2009). «Detecting malaria parasites outside the blood». J Infect Dis199 (11): 1561–3. doi:10.1086/598857. PMID19432543.
Stevenson MM & Riley EM. (2004). «Innate immunity to malaria». Nat Rev Immunol4 (3): 169-80. doi:10.1038/nri1311. PMID15039754.
van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, Bateman ED, Dheda K (2010). «Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD». Eur Respir J35 (1): 27-33. doi:10.1183/09031936.00072909. PMID20044459.
Gómez MI, Prince A (2007). «Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis». Curr Opin Pharmacol7 (3): 244-51. doi:10.1016/j.coph.2006.12.005. PMID17418640.
Klastersky J, Aoun M (2004). «Opportunistic infections in patients with cancer». Ann Oncol15 (suppl 4): 329-35. doi:10.1093/annonc/mdh947. PMID15477331.
d'Enfert C (2009). «Hidden killers: persistence of opportunistic fungal pathogens in the human host». Curr Opin Microbiol12 (4): 358-64. doi:10.1016/j.mib.2009.05.008. PMID19541532.
Utz JF (1962). «The spectrum of opportunistic fungus infections». Lab Invest11: 1018-25. PMID13995588.
Reef SE, Mayer KH (1995). «Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities». Clin Infect Dis21 (Supplement 1): S99-S102. doi:10.1093/clinids/21.Supplement_1.S99. PMID8547520.
Castro KG (1995). «Tuberculosis as an opportunistic disease in persons infected with human immunodeficiency virus». Clin Infect Dis21 (Supplement 1): S66-S71. doi:10.1093/clinids/21.Supplement_1.S66. PMID8547515.
Martínez E, García-Viejo MA, Marcos MA, et al. (2000). «Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy». AIDS14 (16): 2615–26. doi:10.1097/00002030-200011100-00029. PMID11101078.
Vibhagool A, Sungkanuparph S, Mootsikapun P, et al. (2003). «Discontinuation of secondary prophylaxis for Cryptococcal meningitis in Human Immunodeficiency Virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study». Clin Infect Dis36 (10): 1329–31. doi:10.1086/374849. PMID12746781.
Aliouat-Denis, C-M. et al. (2008). «Pneumocystis species, co-evolution and pathogenic power». Infection, Genetics & Evolution8 (5): 708–726. doi:10.1016/j.meegid.2008.05.001. PMID18565802.